We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

84 hedge funds and large institutions have $790M invested in Harmony Biosciences in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 6

256% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 9

47% more funds holding

Funds holding: 57 → 84 (+27)

0.92% more ownership

Funds ownership: 48.28% → 49.2% (+0.92%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

13% less capital invested

Capital invested by funds: $907M → $790M (-$117M)

Holders
84
Holders Change
+27
Holders Change %
+47.37%
% of All Funds
1.46%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
33
Increased
32
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$30.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10.5M
3
N
Nuveen
North Carolina
+$8.31M
4
State Street
State Street
Massachusetts
+$6.46M
5
PA
Perceptive Advisors
New York
+$5.39M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$69.3M
2
NHAS
Novo Holdings A/S
Denmark
-$57.4M
3
LGM
Logos Global Management
California
-$3.3M
4
MWNA
Marshall Wace North America
New York
-$666K
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$566K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$536K +$570K +19,000 New
VEA
52
Virtus ETF Advisers
New York
$440K +$8.43K +281 +2%
AllianceBernstein
53
AllianceBernstein
Tennessee
$415K +$441K +14,700 New
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$355K +$377K +12,567 New
Renaissance Technologies
55
Renaissance Technologies
New York
$333K +$354K +11,800 New
TI
56
Trexquant Investment
Connecticut
$316K +$336K +11,188 New
JP Morgan Chase
57
JP Morgan Chase
New York
$285K -$210K -6,985 -41%
Vontobel Holding
58
Vontobel Holding
Switzerland
$282K – – –
Wells Fargo
59
Wells Fargo
California
$276K +$85.7K +2,857 +41%
MIM
60
MetLife Investment Management
New Jersey
$264K +$280K +9,337 New
CS
61
Credit Suisse
Switzerland
$260K +$276K +9,213 New
DAM
62
Deltec Asset Management
New York
$259K +$275K +9,170 New
VOYA Investment Management
63
VOYA Investment Management
Georgia
$250K +$266K +8,861 New
Invesco
64
Invesco
Georgia
$213K +$226K +7,548 New
MLICM
65
Metropolitan Life Insurance Company (MetLife)
New York
$202K +$214K +7,149 New
Bank of America
66
Bank of America
North Carolina
$155K -$130K -4,327 -44%
Legal & General Group
67
Legal & General Group
United Kingdom
$88K +$74K +2,467 +391%
Royal Bank of Canada
68
Royal Bank of Canada
Ontario, Canada
$65K +$48.7K +1,623 +242%
Citigroup
69
Citigroup
New York
$61K +$37.5K +1,251 +140%
AIP
70
Ameritas Investment Partners
Nebraska
$49K +$37K +1,233 +237%
TRCT
71
Tower Research Capital (TRC)
New York
$48K +$35.9K +1,198 +233%
SO
72
STRS Ohio
Ohio
$42K – – –
FC
73
FORA Capital
Florida
$24K +$25K +835 New
PHK
74
Point72 Hong Kong
Hong Kong
$11K +$11.2K +374 New
EWA
75
Evolution Wealth Advisors
Florida
$8K +$990 +33 +13%
1 2
3
4

HRMY Hedge Fund Activity: Q2 2021 in Review

84 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q2 2021, worth a combined $790M — down 13% from $907M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new HRMY positions and 6 closed out — a net gain of 27 holders — while 32 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $30.2M. The largest seller was Fidelity Investments, cutting an estimated $69.3M.

  • 84 institutional investors held Harmony Biosciences (HRMY) as of Q2 2021, up from 57 in Q1 2021.
  • Funds reported $790M of Harmony Biosciences stock for Q2 2021, down 13% quarter-over-quarter.
  • 33 funds opened new Harmony Biosciences positions in Q2 2021 and 6 closed out, a net change of +27 holders.
  • The largest Harmony Biosciences buyer in Q2 2021 was BlackRock, an estimated $30.2M added.
  • The largest Harmony Biosciences seller in Q2 2021 was Fidelity Investments, an estimated $69.3M sold.

Based on aggregated 13F filings for Q2 2021.